Charles M. Watts - 19 May 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 May 2023, 17:55:33 UTC
Prior SEC filing
04 Apr 2023
Next SEC filing
25 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Charles M. Watts

Key filing fact

Charles M. Watts filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 26 May 2023.

Key facts

  • This page summarizes Charles M. Watts's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 26 May 2023, 17:55.

Change

  • Previous filing in this sequence was filed on 04 Apr 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXDX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+69,619
Change %
Price
$0.000000
Shares after
69,619
Date
19 May 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXDX transaction Derivative

Employee Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-69,619
Change %
-100%
Price
$0.000000*
Shares after
0
Date
19 May 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
69,619
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Charles M. Watts is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 69,619 RSUs, which is eleven of the twelve months.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .